Portfolio company
Oxford Immunotec
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This diagnostics company develops proprietary assays for immunology and infectious diseases, primarily providing tuberculosis testing kits to healthcare providers and laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Limosa Immunodiagnostics
This company develops diagnostic tests for latent tuberculosis and other immune-related diseases for patients and healthcare providers.
The Binding Site
This company manufactures medical diagnostic assays and instruments for clinicians and laboratory professionals to detect and monitor blood cancers and immune system disorders.
Abacus Diagnostica
This company develops molecular diagnostic systems for infectious disease testing, serving hospital laboratories and healthcare units.
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
Inflammatix
This company develops point-of-care molecular diagnostic tests for healthcare providers to identify acute infections and sepsis by reading the body's immune response.
Radisens Diagnostics
This company develops point-of-care diagnostic platforms for rapid blood testing and chronic disease monitoring, serving healthcare providers such as general physicians and hospitals.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Oxford Cancer Biomarkers
This company develops and commercialises precision diagnostic tests and digital pathology tools to help clinicians personalise cancer treatment and assess patient toxicity risks.
